<DOC>
	<DOC>NCT02627131</DOC>
	<brief_summary>The aim of this study was to evaluate the safety and effectiveness of autologous bone marrow mononuclear stem cells in the management of autism.</brief_summary>
	<brief_title>Autologous Bone Marrow Stem Cell Therapy for Autism</brief_title>
	<detailed_description>The aim of this study was to evaluate the safety and effectiveness of autologous bone marrow mononuclear stem cells in the management of autism of 24 patients at Vinmec International Hospital, Hanoi, Vietnam</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<criteria>Confirmed diagnosis of autism according to the Diagnostic and Statistical ManualIV (DSMIV) diagnostic criteria for autistic disorder Epilepsy Hydrocephalus with ventricular drain Coagulation disorders Allergy to anesthetic agents Severe health conditions such as cancer, failure of heart, lung, liver or kidney Active infections Severe psychiatric disorders</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Autism</keyword>
	<keyword>Stem Cells</keyword>
</DOC>